+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of Biologic, and Key Geographical Regions

  • PDF Icon

    Report

  • 224 Pages
  • May 2024
  • Region: Global
  • Roots Analysis
  • ID: 5759603

Surge in Single-Use Systems and Automation Reduces Costs and Environmental Impact

The global bioreactors market is estimated to grow from $16.7 billion in 2024 to $51.7 billion by 2035, representing a CAGR of 11.1% during the forecast period from 2024 to 2035. The global expansion of biopharmaceutical products has led to significant growth in the bioprocessing supplies market. Over the past two decades, this market has consistently grown at an annual rate of between 12 and 14%.

With companies either establishing their own biopharmaceutical manufacturing facilities or outsourcing production to biologics contract manufacturing organizations (CDMOs / CMOs), the demand for clinical and commercial-scale bioreactors has surged considerably. In fact, the research suggests that the current bioreactors capacity, including the captive and outsourced capacity, amounts to over 13 million liters, globally.

Given the immense demand, the bioreactors market has grown to be competitive market with a large number of active companies possessing the expertise to design, engineer and manufacture diverse types of bioreactors (in term of design and mechanism of action) for varying applications. Some examples of their offerings include stainless steel bioreactors, disposable / single use bioreactors, stirred-tank bioreactors, small scale bioreactors, air lift bioreactors, perfusion bioreactors, bubble column bioreactors, and photobioreactors.

Bioreactors Market Share Insights

The market research report presents an in-depth analysis of the various companies that are engaged in the bioreactors industry, across different segments, as defined below:

  • Historical Trend: 2018-2023
  • Base Year: 2024
  • Forecast Period: 2024-2035
  • Market Size in 2024: $ 16.7 Billion
  • CAGR: 11.1%
  • Fabrication Material
    • Stainless Steel
    • Single Use
    • Glass
  • Type of Bioprocess
    • Batch and Fed-batch
    • Continuous
  • Type of Biologic
    • Antibodies
    • Vaccines
    • Cell Therapies
    • Other Biologics
  • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World
  • Key Companies Profiled
    • Applikon Biotechnology
    • Bionet
    • Cytiva
    • Eppendorf
    • Merck
    • Ollital Technology
    • Parr Instrument Company
    • Sartorius
    • Shanghai Bailun Biological Technology
    • Solaris Biotech
    • Solida Biotech
    • Zhengzhou Laboao Instrument Equipment (LABAO)
    • (Full list of 250 companies captured is available in the report)
  • Customization Scope: 15% Free Customization Option (equivalent to 5 analyst working days)
    • Excel Data Packs (Complimentary)
    • Market Landscape Analysis
    • Company Competitiveness Analysis
    • Capacity Analysis
    • Market Forecast and Opportunity Analysis

Bioreactors Market Segmentation Overview

Market Share by Fabrication Material

Based on the fabrication material, the global bioreactor market is categorized into stainless steel bioreactors, single use bioreactors and glass bioreactors. The stainless steel bioreactors segment occupies the highest share in 2024. Further, the single use / disposable bioreactors segment is anticipated to show the highest market growth potential during the forecast period. This surge in the market is attributed to the increasing demand for emerging biologic modalities such as cell and gene therapy products as well as antibody drug conjugates, which require more flexible and smaller-scale production solutions. Single use / disposable bioreactors offer quick turnaround times, scalability, flexibility, and reduced risk of cross-contamination, making them ideal for multiproduct facilities in bioprocessing. Recently, ABEC introduced its 4000-L and 6000-L disposable bioreactors, and Thermo Fisher unveiled its 5000-L disposable bioreactor, addressing unmet market needs for high volume single use bioreactors which can deliver performance comparable to that of stainless steel bioreactors.

Market Share by Type of Bioprocess

Based on type of bioprocess, the bioreactors market is categorized into batch and fed-batch, and continuous. The batch and fed-batch bioreactors segment currently occupies the highest market share and this trend is expected to remain same during the forecast period. Further, the continuous bioreactors segment is projected to grow at a relatively higher growth rate during the forecast period. Continuous bioprocessing integrates sequential steps, thereby reducing downtime, streamlining labor-intensive processes, and mitigating contamination risks. Many biopharmaceutical companies, particularly large contract manufacturers, are either adopting or contemplating the implementation of continuous bioprocessing technologies including the perfusion bioreactors. In December 2022, Merck acquired Erbi Biosystems, a developer of the 2 ml continuous perfusion cell culture platform technology, enabling scalable perfusion bioreactor processes from 2 ml to 2,000 L with rapid lab-scale process development.

Market Share by Type of Biologic

Based on the type of biologic, the bioreactors market is segmented into antibodies, vaccines, cell therapies and other biologics. Presently, the market is dominated by revenues generated from the sales of bioreactors for manufacturing antibodies. Antibodies are experiencing rapid growth in the biomanufacturing industry due to their versatility, specificity, and efficacy in targeting diseases. According to the Umabs Antibody Therapies Database, till 2023, over 170 therapeutic antibodies have been approved by at least one regulatory agency in the world, whereas several hundred are in development. Beyond the traditional monoclonal antibodies, these modalities are available / under development in various formats, including bi-specific antibodies, antibody-drug conjugates (ADCs), antibody fragments, and Fc fusion proteins, thereby offering tailored approaches to address different diseases and therapeutic challenges, contributing to the growing traction of antibodies in the biomanufacturing landscape.

Market Share by Key Geographical Regions

Based on the key geographical regions, the global bioreactors market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Europe dominated the bioreactor market and accounted for the largest revenue share in 2024. It is worth noting that the US has the highest count for bioprocessing facilities, while Europe, known for its large-scale plants, holds the largest capacity. Further, the Asia-Pacific region is rapidly expanding the number of biomanufacturing facilities, although with relatively lower capacities.

Bioreactors Market Key Insights

The market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the bioreactor manufacturers. The market report highlights the efforts of several bioreactor developers engaged in this rapidly growing segment of the biomanufacturing equipment industry. Key takeaways of the market report are briefly discussed below.

Market Landscape Analysis: Bioreactor Manufacturers

The bioreactors market landscape features around 250 companies, which claim to possess the necessary technical expertise for manufacturing high-quality bioreactors to serve the needs of a wide range of end users, including biopharmaceutical companies, CMOs and CROs, and academic and research institutes. The players can either be original equipment manufacturers (OEMs) that produce different components of bioreactors, and / or engineering, procurement, and construction (EPCs) companies that integrate all the equipment designed by OEM engineers into a complete performing system. According to the research, the Asia-Pacific region has emerged as the key hub in this domain, featuring the presence of 122 bioreactor manufacturers.

The demand for high throughput bioreactor systems has led to the establishment of several start-ups in this field, which constitute 54% of the overall players engaged in this domain. While commercial scale capacity predominates globally, nearly 75% of the companies are involved in manufacturing bioreactors for preclinical purposes, primarily for drug screening, efficacy / toxicity testing, working with microbiological process for small biotech production facilities, and scientific and laboratory research.

Market Drivers Analysis: The Expansion of CMO Services to Encompass a Broader Range of Biopharmaceutical Products is Propelling the Bioreactors Market

As biomanufacturing demands substantial capital investment, there's a growing trend towards outsourcing various operations to CMOs and CDMOs, particularly specialized, repetitive, or non-core activities. Currently, over 305 biologics contract manufacturers offer diverse services for biologics, indicating a thriving outsourcing market. This trend is expected to continue, with outsourcing projected to outpace captive biopharmaceutical growth, driving increased demand for bioreactors. Additionally, factors like the COVID-19 pandemic, which initially boosted the bioreactors market due to their role in efficient vaccine production further contribute to the demand for bioreactors.

Further, the growth of the market is closely linked to the increasing popularity of biosimilars and biobetters, particularly following the patent expiration of blockbuster biologics. After 2025, several high-profile biologics, such as Humira (adalimumab) and Rituxan (rituximab), are expected to lose patent protection, opening up opportunities for biosimilar manufacturers to enter the market. Moreover, as biosimilars and biobetters gain acceptance in the healthcare industry due to their cost-effectiveness and therapeutic advantages, the demand for bioprocessing technologies to support the production of these next-generation biopharmaceuticals is likely witness substantial growth.

Market Trends Analysis: Emphasis on Automation and Sustainability in Bioreactors Market

The bioreactors market is witnessing a significant shift towards sustainable practices, evident in the development of bioreactors designed to minimize energy consumption, waste generation, and environmental impact. This emphasis on sustainability has led to the increased adoption of single use / disposable bioreactors, which offer benefits such as a 45% reduction in water and energy consumption and a 40% decrease in initial investment costs. In fact, two-thirds of clinical bioproduction processes leverage single use components. the research suggests that nearly 25% of the bioreactor manufacturers provide single use / disposable bioreactors.

Moreover, there is a growing investment by stakeholders engaged in this domain in enhancing bioprocessing efficiency through automation, advanced control systems, and data analytics. More than 60% of bioreactor manufacturers now offer fully automated bioreactors. These are often integrated with digital biomanufacturing technologies like Process Analytical Technology (PAT) systems which enable real-time monitoring and control of critical process parameters (CPPs) like temperature, pH, dissolved oxygen, and biomass concentration throughout the bioprocess. Additionally, Cleaning in Place (CIP) and Sterilization in Place (SIP) features are becoming the mainstream requirements in bioreactor specifications, owing to the strict guidelines set by GMP and FDA standards. The industry is also embracing modular bioreactors that can be configured sequentially or in parallel, facilitating comparative studies and parallel experiments with ease and consistency.

Bioreactors Market Size Analysis: Batch and Fed-batch Holds the Largest Market Share

Batch and fed-batch bioprocess currently hold the majority share within the global bioreactors market. These methods, although traditional, are still viewed as simpler, cost-effective, and associated with fewer failures. In addition, fed-batch processing has led to an improvement in product titer, as well as the molecule’s key quality attributes.

Key Manufacturers in Bioreactors Market

The key players engaged in this domain (which have also been captured in this report) include Applikon Biotechnology, Bionet, Cytiva, Eppendorf, Merck, Ollital Technology, Parr Instrument Company, Sartorius, Shanghai Bailun Biological Technology, Solaris Biotech, Solida Biotech and Zhengzhou Laboao Instrument Equipment (LABAO). This market report includes an easily searchable, excel database of all the bioreactor manufacturers, worldwide.

Recent Developments in the Global Bioreactors Market

Several recent developments have taken place in the field of bioreactors. the analyst has outlined some of these recent initiatives below. These developments, even if they took place post the release of the market report, substantiate the overall bioreactors market trends that have been outlined in the analysis.

  • In December 2023, Cellexus BioreactorSystems presented their proprietary airlift single use disposable bioreactor systems at the CPHI Barcelona 2023.
  • In October 2023, the Washington State University researchers announced the development of a minifridge-sized bioreactor capable of manufacturing T cells at 95% of the maximum growth rate, which is about 30% faster than the current technologies.
  • In April 2023, Cytiva launched the 50 or 200 L size X-platform bioreactors, which claim to increase process efficiency through ergonomic improvements.
  • In April 2023, BioMADE announced the commencement of five new projects that focus on developing more efficient, lower-cost, flexible, and re-deployable bioreactors to advance the US bioeconomy and biomanufacturing goals.

Bioreactors Market Report Coverage

The report presents an in-depth bioreactors market analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different regions. Amongst other elements, the report includes:

  • An executive summary of the insights captured during the research, offering a high-level view on the current state of the global bioreactors market and its likely evolution in the mid-long term.
  • A general introduction to bioreactors, along with details related to the components of a bioreactor. Additionally, the chapter presents information on different types of bioreactors based on type of bioprocess and mode of action. Further, it concludes with a discussion on applications of bioreactors and future perspectives in this domain.
  • A detailed assessment of the overall market landscape of companies manufacturing bioreactors, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), region of headquarters, geographical reach (North America, Europe, Asia-Pacific and Rest of the World), capacity (micro-mini, small-scale, bench-scale, lab-scale, pilot-scale and large-scale), scale of operation (preclinical, clinical and commercial), scalability, type of bioprocess (batch, fed-batch and continuous), type of cell culture (2D cell culture, 3D cell culture and 4D cell culture), mode of operation (manual, semi-automatic and automatic) and type of end user (academic institutes and research laboratories, biopharmaceutical and pharmaceutical industries, contract manufacturing organizations, and contract research organizations).
  • A detailed competitiveness analysis of bioreactor manufacturers based on manufacturer strength (in terms of years of experience and company size), portfolio strength (considering geographical reach, number of products in portfolio, type of bioreactor, capacity, scale of operation, scalability, type of bioprocess, type of cell culture, mode of operation and end users).
  • Elaborate profiles of key players manufacturing bioreactors (shortlisted on the basis of cumulative strength of manufacturers and product portfolio); each profile includes a brief overview of the company, along with information on its financial information (if available), product portfolio, recent developments and an informed future outlook.
  • An estimate of the global installed bioreactors capacity of biologics, based on information provided by various industry stakeholders in the public domain. It also features distribution of the available capacity on the basis of fabrication material (glass, stainless steel and single use), source of cell culture (mammalian, microbial and others), reactor volume (less than 2,000 L, 2,000 to 5,000 L, 5,001 to 10,000 L and more than 10,000 L), type of manufacturer (in-house, hybrid and CMOs) and key geographical regions (North America, Europe, and Asia-Pacific and Rest of the World).
  • A case study on the market landscape of bioprocess controllers and automation systems, providing information on scale of operation (laboratory, clinical, and commercial), key features (scalability / ease to use, visual data display, remote accessibility, built-in system control sensors, expansive I/O compatibility and provisions for alarms / alerts), compatibility with bioreactor system (stirred tank (glass), single use bioreactor, stirred tank (steel), rocking motion), type of bioprocess (batch, fed-batch and perfusion), and type of process controlled (cell cultivation and microbial fermentation). In addition, the chapter presents details of companies involved in the development of bioprocess control software, upstream and downstream controllers, including information on their year of establishment, company size, and location of headquarters.
  • A detailed market forecast analysis in order to estimate the existing market size and future opportunity for the bioreactors market over the next 11 years. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the market size during the forecast period 2024-2035. The chapter presents detailed projections of the current and future opportunity within the market across different fabrication material (glass, stainless steel and single use), type of bioprocess (batch, fed-batch and continuous), type of biologic (antibodies, vaccines, cell therapies and other biologics), and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the World).

One of the key objectives of this market report was to estimate the current market size, opportunity and the future growth potential for bioreactor manufacturers, over the forecast period. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the market evolution during the forecast period 2024-2035.

The market report also features the likely distribution of the current and forecasted opportunity within the bioreactors market across various segments, such as fabrication material (stainless steel bioreactors, single use bioreactors and glass bioreactors), type of bioprocess (batch and fed-batch, and continuous), type of biologic (antibodies, vaccines cell therapies and other biologics), and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the World).

In order to account for future uncertainties and to add robustness to the model, the analyst has provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in the bioreactors market report were influenced by discussions held with stakeholders in the industry. The report features detailed transcripts of interviews held with the following industry stakeholders:

  • Director and Business Unit Head, Power and Energy, Oil and Gas, and Renewable Energy, Small Company, India
  • Founder and Director, Mid-sized Company, India
  • Chief Executive Officer, Small Company, Denmark
  • Chief Commercial Officer, Small Company, Denmark

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the Bioreactors Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Bioreactors
3.3. Components of a Bioreactor
3.4. Types of Bioreactors
3.4.1. Classification based on Type of Bioprocess
3.4.2. Classification based on Mode of Action
3.5. Applications of Bioreactors
3.6. Future Perspectives
4. BIOREACTOR MANUFACTURERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Bioreactor Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Region of Headquarters
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Year of Establishment and Region of Headquarters
4.2.6. Analysis by Company Size and Region of Headquarters
4.2.7. Analysis by Year of Establishment, Company Size and Region of Headquarters
4.2.8. Analysis by Geographical Reach
4.2.9. Analysis by Region of Headquarters and Geographical Reach
4.2.10. Analysis by Capacity
4.2.11. Analysis by Scale of Operation
4.2.12. Analysis by Scalability
4.2.13. Analysis by Type of Bioprocess
4.2.14. Analysis by Type of Cell Culture
4.2.15. Analysis by Mode of Operation
4.2.16. Analysis by Type of End-user
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis: Small Companies
5.4.1. Company Competitiveness Analysis: Small Companies based in North America
5.4.2. Company Competitiveness Analysis: Small Companies based in Europe
5.4.3. Company Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World
5.5. Company Competitiveness Analysis: Mid-sized Companies
5.5.1. Company Competitiveness Analysis: Mid-sized Companies based in North America
5.5.2. Company Competitiveness Analysis: Mid-sized Companies based in Europe
5.5.3. Company Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World
5.6. Company Competitiveness Analysis: Large and Very Large Companies
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Applikon Biotechnology (acquired by Getinge)
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Bionet
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Cytiva
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. Eppendorf
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Product Portfolio
6.5.4. Recent Developments and Future Outlook
6.6. Merck
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Product Portfolio
6.6.4. Recent Developments and Future Outlook
6.7. Ollital Technology
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Parr Instrument Company
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook
6.9. Sartorius
6.9.1. Company Overview
6.9.2. Financial Information
6.9.3. Product Portfolio
6.9.4. Recent Developments and Future Outlook
6.10. Shanghai Bailun Biological Technology
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook
6.11. Solaris Biotech (acquired by Donaldson Company)
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook
6.12. Solida Biotech
6.12.1. Company Overview
6.12.2. Product Portfolio
6.12.3. Recent Developments and Future Outlook
6.13. Zhengzhou Laboao Instrument Equipment (LABAO)
6.13.1. Company Overview
6.13.2. Product Portfolio
6.13.3. Recent Developments and Future Outlook
7. CAPACITY ANALYSIS
7.1. Chapter Overview
7.2. Key Assumptions and Methodology
7.2.1 Bioreactors s: Global Installed Capacity of Biologics
7.2.1.1. Analysis by Fabrication Material
7.2.1.2. Analysis by Source of Cell Culture
7.2.1.3. Analysis by Reactor Volume
7.2.1.4. Analysis by Type of Manufacturer
7.2.1.5. Analysis by Key Geographical Regions
7.3. Concluding Remarks
8. CASE STUDY: BIOPROCESS CONTROLLERS AND AUTOMATION SYSTEMS
8.1. Chapter Overview
8.2. Bioprocess Control Software: Overall Market Landscape
8.2.1. Analysis by Scale of Operation
8.2.2. Analysis by Key Features
8.2.3. Analysis by Compatibility with System
8.2.4. Analysis by Type of Process Controlled
8.3. Bioprocess Control Software Developers: Overall Market Landscape
8.3.1. Analysis by Year of Establishment
8.3.2. Analysis by Company Size
8.3.3. Analysis by Location of Headquarters
8.4. Upstream Controllers: Overall Market Landscape
8.4.1. Analysis by Scale of Operation
8.4.2. Analysis by Key Features
8.4.3. Analysis by Compatibility with Bioreactor System
8.4.4. Analysis by Type of Bioprocess
8.4.5. Analysis by Type of Process Controlled
8.5. Upstream Controller Developers: Overall Market Landscape
8.5.1. Analysis by Year of Establishment
8.5.2. Analysis by Company Size
8.5.3. Analysis by Location of Headquarters
8.6. Downstream Controller Systems: Overall Market Landscape
8.6.1. Analysis by Scale of Operation
8.6.2. Analysis by Key Features
8.6.3. Analysis by Type of System
8.6.4. Analysis by Type of Bioprocess
8.6.5. Analysis by Application Area
8.7. Downstream Controller System Developers: Overall Market Landscape
8.7.1. Analysis by Year of Establishment
8.7.2. Analysis by Company Size
8.7.3. Analysis by Location of Headquarters
9. MARKET FORECAST
9.1. Chapter Overview
9.2. Key Assumptions and Forecast Methodology
9.3. Global Bioreactors Market, 2023-2035: Distribution by Fabrication Material
9.3. 1. Global Glass Bioreactors Market, 2023-2035
9.3. 2. Global Stainless Steel Bioreactors Market, 2023-2035
9.3. 3. Global Single use Bioreactors Market, 2023-2035
9.4. Global Bioreactors Market, 2023-2035: Distribution by Type of Bioprocess
9.3.3.1. Global Bioreactors Market for Batch and Fed-batch Process, 2023-2035
9.3.3.2. Global Bioreactors Market for Continuous Process, 2023-2035
9.3.4. Global Bioreactors Market, 2023-2035: Distribution by Type of Biologic
9.3.4.1. Global Bioreactors Market for Antibodies, 2023-2035
9.3.4.2. Global Bioreactors Market for Vaccines, 2023-2035
9.3.4.3. Global Bioreactors Market for Cell Therapies, 2023-2035
9.3.4.4. Global Bioreactors Market for Other Biologics, 2023-2035
9.3.5. Global Bioreactors Market, 2023-2035: Distribution by Key Geographical Regions
9.3.5.1. Global Bioreactors Market in North America, 2023-2035
9.3.5.2. Global Bioreactors Market in Europe, 2023-2035
9.3.5.3. Global Bioreactors Market in Asia-Pacific, 2023-2035
9.3.5.4. Global Bioreactors Market in Rest of the World, 2023-2035
10. EXECUTIVE INSIGHTS11. CONCLUDING REMARKS12. APPENDIX 1: TABULATED DATA13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Capacity Analysis
Figure 2.3 Executive Summary: Market Forecast
Figure 3.1 Components of a Bioreactor
Figure 3.2 Types of Bioreactors (based on Type of Bioprocess)
Figure 3.3 Types of Bioreactors (based on Mode of Action)
Figure 3.4 Industries Employing Bioreactors
Figure 3.5 Applications of Bioreactors in Pharmaceutical Industry
Figure 4.1 Bioreactor Manufacturers: Distribution by Year of Establishment
Figure 4.2 Bioreactor Manufacturers: Distribution by Company Size
Figure 4.3 Bioreactor Manufacturers: Distribution by Region of Headquarters
Figure 4.4 Bioreactor Manufacturers: Distribution by Location of Headquarters
Figure 4.5 Bioreactor Manufacturers: Distribution by Year of Establishment and Region of Headquarters
Figure 4.6 Bioreactor Manufacturers: Distribution by Company Size and Region of Headquarters
Figure 4.7 Bioreactor Manufacturers: Distribution by Year of Establishment, Company Size and Region of Headquarters
Figure 4.8 Bioreactor Manufacturers: Distribution by Geographical Reach
Figure 4.9 Bioreactor Manufacturers: Distribution by Region of Headquarters and Geographical Reach
Figure 4.10 Bioreactor Manufacturers: Distribution by Capacity
Figure 4.11 Bioreactor Manufacturers: Distribution by Scale of Operation
Figure 4.12 Bioreactor Manufacturers: Distribution by Scalability
Figure 4.13 Bioreactor Manufacturers: Distribution by Type of Bioprocess
Figure 4.14 Bioreactor Manufacturers: Distribution by Type of Cell Culture
Figure 4.15 Bioreactor Manufacturers: Distribution by Mode of Operation
Figure 4.16 Bioreactor Manufacturers: Distribution by Type of End-user
Figure 5.1 Competitiveness Analysis: Small Companies
Figure 5.2 Competitiveness Analysis: Small Companies based in North America
Figure 5.3 Competitiveness Analysis: Small Companies based in Europe
Figure 5.4 Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World
Figure 5.5 Competitiveness Analysis: Mid-sized Companies
Figure 5.6 Competitiveness Analysis: Mid-sized Companies based in North America
Figure 5.7 Competitiveness Analysis: Mid-sized Companies based in Europe
Figure 5.8 Competitiveness Analysis: Mid-sized Companies based in Asia-Pacific and Rest of the World
Figure 5.9 Competitiveness Analysis: Large and Very Large Companies
Figure 5.10 Competitiveness Analysis of Bioreactor Manufacturers: Competitiveness Score of Top Players
Figure 6.1 Cytiva: Annual Revenues, FY 2017-FY 2021 (USD Million)
Figure 6.2 Eppendorf: Annual Revenues, FY 2017-FY 2021 (EUR Million)
Figure 6.3 Merck: Annual Revenues, FY 2017-FY 2022 (EUR Billion)
Figure 6.4 Sartorius: Annual Revenues, FY 2017-FY 2022 (EUR Billion)
Figure 7.1 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Fabrication Material
Figure 7.2 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Source of Cell Culture
Figure 7.3 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Reactor Volume
Figure 7.4 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Type of Manufacturer
Figure 7.5 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Key Geographical Regions
Figure 8.1 Bioprocess Control Software: Distribution by Scale of Operation
Figure 8.2 Bioprocess Control Software: Distribution by Key Features
Figure 8.3 Bioprocess Control Software: Distribution by Compatibility with System
Figure 8.4 Bioprocess Control Software: Distribution by Type of Process Controlled
Figure 8.5 Bioprocess Control Software Developers: Distribution by Year of Establishment
Figure 8.6 Bioprocess Control Software Developers: Distribution by Company Size
Figure 8.7 Bioprocess Control Software Developers: Distribution by Location of Headquarters
Figure 8.8 Upstream Controllers: Distribution by Scale of Operation
Figure 8.9 Upstream Controllers: Distribution by Key Features
Figure 8.10 Upstream Controllers: Distribution by Compatibility with Bioreactor System
Figure 8.11 Upstream Controllers: Distribution by Type of Bioprocess
Figure 8.12 Upstream Controllers: Distribution by Type of Process Controlled
Figure 8.13 Upstream Controller Developers: Distribution by Year of Establishment
Figure 8.14 Upstream Controller Developers: Distribution by Company Size
Figure 8.15 Upstream Controller Developers: Distribution by Location of Headquarters
Figure 8.16 Downstream Controller Systems: Distribution by Scale of Operation
Figure 8.17 Downstream Controller Systems: Distribution by Key Features
Figure 8.18 Downstream Controller Systems: Distribution by Type of System
Figure 8.19 Downstream Controller Systems: Distribution by Type of Bioprocess
Figure 8.20 Downstream Controller Systems: Distribution by Application Area
Figure 8.21 Downstream Controller System Developers: Distribution by Year of Establishment
Figure 8.22 Downstream Controller System Developers: Distribution by Company Size
Figure 8.23 Downstream Controller System Developers: Distribution by Location of Headquarters
Figure 9.1 Global Bioreactors Market, 2023-2035 (USD Billion)
Figure 9.2 Global Bioreactors Market, 2023-2035: Distribution by Fabrication Material
Figure 9.3 Global Glass Bioreactors Market, 2023-2035
Figure 9.4 Global Stainless Steel Bioreactors Market, 2023-2035
Figure 9.5 Global Single use Bioreactors Market, 2023-2035
Figure 9.6 Global Bioreactors Market, 2023-2035: Distribution by Type of Bioprocess
Figure 9.7 Global Bioreactors Market for Batch and Fed-batch Process, 2023-2035
Figure 9.8 Global Bioreactors Market for Continuous Process, 2023-2035
Figure 9.9 Global Bioreactors Market, 2023-2035: Distribution by Type of Biologic
Figure 9.10 Global Bioreactors Market for Antibodies, 2023-2035
Figure 9.11 Global Bioreactors Market for Vaccines, 2023-2035
Figure 9.12 Global Bioreactors Market for Cell Therapies, 2023-2035
Figure 9.13 Global Bioreactors Market for Other Biologics, 2023-2035
Figure 9.14 Global Bioreactors Market, 2023-2035: Distribution by Key Geographical Regions
Figure 9.15 Bioreactors Market in North America, 2023-2035
Figure 9.16 Bioreactors Market in Europe, 2023-2035
Figure 9.17 Bioreactors Market in Asia-Pacific, 2023-2035
Figure 9.18 Bioreactors Market in Rest of the World, 2023-2035
Figure 11.1 Concluding Remarks: Overall Market Landscape of Bioreactor Manufacturers
Figure 11.2 Concluding Remarks: Geographical Distribution of Bioreactor Manufacturers
Figure 11.3 Concluding Remarks: Capacity Analysis
Figure 11.4 Concluding Remarks: Market Forecast
LIST OF TABLES
Table 4.1 Bioreactor Manufacturers: List of Companies
Table 4.2 Bioreactor Manufacturers: Information on Geographical Reach
Table 4.3 Bioreactor Manufacturers: Information on Volume and Type of Bioreactor
Table 4.4 Bioreactor Manufacturers: Information on Scale of Operation and Scalability
Table 4.5 Bioreactor Manufacturers: Type of Bioprocess and Type of Cell Culture
Table 4.6 Bioreactor Manufacturers: Information on Mode of Operation and Type of End-user
Table 6.1 Bioreactor Manufacturers: List of Profiled Companies
Table 6.2 Applikon Biotechnology: Company Snapshot
Table 6.3 Applikon Biotechnology: Bioreactor Portfolio
Table 6.4 Applikon Biotechnology: Recent Developments and Future Outlook
Table 6.5 Bionet: Company Snapshot
Table 6.6 Bionet: Bioreactor Portfolio
Table 6.7 Bionet: Recent Developments and Future Outlook
Table 6.8 Cytiva: Company Snapshot
Table 6.9 Cytiva: Bioreactor Portfolio
Table 6.10 Cytiva: Recent Developments and Future Outlook
Table 6.11 Eppendorf: Company Snapshot
Table 6.12 Eppendorf: Bioreactor Portfolio
Table 6.13 Eppendorf: Recent Developments and Future Outlook
Table 6.14 Merck: Company Snapshot
Table 6.15 Merck: Bioreactor Portfolio
Table 6.16 Merck: Recent Developments and Future Outlook
Table 6.17 Ollital Technology: Company Snapshot
Table 6.18 Ollital Technology: Bioreactor Portfolio
Table 6.19 Ollital Technology: Recent Developments and Future Outlook
Table 6.20 Parr Instrument Company: Company Snapshot
Table 6.21 Parr Instrument Company: Bioreactor Portfolio
Table 6.22 Parr Instrument Company: Recent Developments and Future Outlook
Table 6.23 Sartorius: Company Snapshot
Table 6.24 Sartorius: Bioreactor Portfolio
Table 6.25 Sartorius: Recent Developments and Future Outlook
Table 6.26 Shanghai Bailun Biological Technology: Company Snapshot
Table 6.27 Shanghai Bailun Biological Technology: Bioreactor Portfolio
Table 6.28 Shanghai Bailun Biological Technology: Recent Developments and Future Outlook
Table 6.29 Solaris Biotech: Company Snapshot
Table 6.30 Solaris Biotech: Bioreactor Portfolio
Table 6.31 Solaris Biotech: Recent Developments and Future Outlook
Table 6.32 Solida Biotech: Company Snapshot
Table 6.33 Solida Biotech: Bioreactor Portfolio
Table 6.34 Solida Biotech: Recent Developments and Future Outlook
Table 6.35 Zhengzhou Laboao Instrument Equipment (LABAO): Company Snapshot
Table 6.36 Zhengzhou Laboao Instrument Equipment (LABAO): Bioreactor Portfolio
Table 6.37 Zhengzhou Laboao Instrument Equipment (LABAO): Recent Developments and Future Outlook
Table 7.1 Capacity Analysis: Information on Contract Biomanufacturing Capacity
Table 7.2 Capacity Analysis: Average Capacity per Category (Sample Data Set)
Table 7.3 Capacity Analysis: Average Capacity for Mammalian Expression System (Sample Data Set)
Table 7.4 Capacity Analysis: Average Capacity for Microbial Expression System (Sample Data Set)
Table 7.5 Capacity Analysis: Global Distribution of Contract, in-house and Hybrid Biomanufacturing Capacity
Table 8.1 Bioprocess Control Software: Information on Key Features, Compatibility with Bioreactor System and Process Controlled
Table 8.2 Upstream Controllers: Information on Key Features, Type of Bioprocess and Compatibility with Bioreactor System
Table 8.3 Downstream Controller Systems: Information on Key Features, Type of System, Type of Bioprocess and Application Area
Table 10.1 Ensofa Projects: Key Highlights
Table 10.2 Sunrise Process Equipment: Key Highlights
Table 10.3 CerCell: Key Highlights
Table 10.4 CelVivo: Key Highlights
Table 12.1 Bioreactor Manufacturers: Distribution by Year of Establishment
Table 12.2 Bioreactor Manufacturers: Distribution by Company Size
Table 12.3 Bioreactor Manufacturers: Distribution by Region of Headquarters
Table 12.4 Bioreactor Manufacturers: Distribution by Location of Headquarters
Table 12.5 Bioreactor Manufacturers: Distribution by Year of Establishment and Region of Headquarters
Table 12.6 Bioreactor Manufacturers: Distribution by Company Size and Region of Headquarters
Table 12.7 Bioreactor Manufacturers: Distribution by Year of Establishment, Company Size and Region of Headquarters
Table 12.8 Bioreactor Manufacturers: Distribution by Geographical Reach
Table 12.9 Bioreactor Manufacturers: Distribution by Region of Headquarters Region and Geographical Reach
Table 12.10 Bioreactor Manufacturers: Distribution by Capacity
Table 12.11 Bioreactor Manufacturers: Distribution by Scale of Operation
Table 12.12 Bioreactor Manufacturers: Distribution by Scalability
Table 12.13 Bioreactor Manufacturers: Distribution by Type of Bioprocess
Table 12.14 Bioreactor Manufacturers: Analysis by Type of Cell Culture
Table 12.15 Bioreactor Manufacturers: Analysis by Mode of Operation
Table 12.16 Bioreactor Manufacturers: Analysis by Type of End-user
Table 12.17 Cytiva: Annual Revenues, FY 2017-FY 2021 (USD Million)
Table 12.18 Eppendorf: Annual Revenues, FY 2017-FY 2021 (EUR Million)
Table 12.19 Merck: Annual Revenues, FY 2017-FY 2022 (EUR Billion)
Table 12.20 Sartorius: Annual Revenues, FY 2017-FY 2022 (EUR Billion)
Table 12.21 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Fabrication Material
Table 12.22 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Source of Cell Culture
Table 12.23 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Reactor Volume
Table 12.24 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Type of Manufacturer
Table 12.25 Global Installed Bioreactors Capacity (by Million Liters): Distribution by Key Geographical Regions
Table 12.26 Bioprocess Control Software: Distribution by Scale of Operation
Table 12.27 Bioprocess Control Software: Distribution by Key Features
Table 12.28 Bioprocess Control Software: Distribution by Compatibility with Systems
Table 12.29 Bioprocess Control Software: Distribution by Type of Process Controlled
Table 12.30 Bioprocess Control Software Developers: Distribution by Year of Establishment
Table 12.31 Bioprocess Control Software Developers: Distribution by Company Size
Table 12.32 Bioprocess Control Software Developers: Distribution by Location of Headquarters
Table 12.33 Upstream Controllers: Distribution by Scale of Operation
Table 12.34 Upstream Controllers: Distribution by Key Features
Table 12.35 Upstream Controllers: Distribution by Compatibility with Bioreactor Systems
Table 12.36 Upstream Controllers: Distribution by Type of Bioprocess
Table 12.37 Upstream Controllers: Distribution by Type of Process Controlled
Table 12.38 Upstream Controller Developers: Distribution by Year of Establishment
Table 12.39 Upstream Controller Developers: Distribution by Company Size
Table 12.40 Upstream Controller Developers: Distribution by Location of Headquarters
Table 12.41 Downstream Controller Systems: Distribution by Scale of Operation
Table 12.42 Downstream Controller Systems: Distribution by Key Features
Table 12.43 Downstream Controller Systems: Distribution by Type of System
Table 12.44 Downstream Controller Systems: Distribution by Type of Bioprocess
Table 12.45 Downstream Controller Systems: Distribution by Application Area
Table 12.46 Downstream Controller System Developers: Distribution by Year of Establishment
Table 12.47 Downstream Controller System Developers: Distribution by Company Size
Table 12.48 Downstream Controller System Developers: Distribution by Location of Headquarters
Table 12.49 Global Bioreactors Market, 2023-2035 (USD Billion)
Table 12.50 Global Bioreactors Market, 2023-2035: Distribution by Fabrication Material
Table 12.51 Global Glass Bioreactors Market, 2023-2035
Table 12.52 Global Stainless Steel Bioreactors Market, 2023-2035
Table 12.53 Global Single use Bioreactors Market, 2023-2035
Table 12.54 Global Bioreactors Market, 2023-2035: Distribution by Type of Bioprocess
Table 12.55 Global Bioreactors Market for Batch and Fed-batch Process, 2023-2035
Table 12.56 Global Bioreactors Market for Continuous Process, 2023-2035
Table 12.57 Global Bioreactors Market, 2023-2035: Distribution by Type of Biologic
Table 12.58 Global Bioreactors Market for Antibodies, 2023-2035
Table 12.59 Global Bioreactors Market for Vaccines, 2023-2035
Table 12.60 Global Bioreactors Market for Cell Therapies, 2023-2035
Table 12.61 Global Bioreactors Market for Other Biologics, 2023-2035
Table 12.62 Global Bioreactors Market, 2023-2035: Distribution by Key Geographical Regions
Table 12.63 Bioreactors Market in North America, 2023-2035
Table 12.64 Bioreactors Market in Europe, 2023-2035
Table 12.65 Bioreactors Market in Asia-Pacific, 2023-2035
Table 12.66 Bioreactors Market in Rest of the World, 2023-2035

Executive Summary

Bioreactors are specialized vessels used in upstream biomanufacturing to cultivate cells (microorganisms, plant and animal cells), and tissues, under controlled conditions. They are designed to provide the ideal growth environment with ambient temperature, pH, pressure, aeration and nutrients to the live cells or cellular components for converting the substrates into various types of biological products.

These biological products can range from therapeutic proteins such as vaccines, fusion proteins, antibodies, hormones, interleukins and enzymes to several advanced medicinal products (ATMPs), namely cell-based and oligonucleotide-based therapies, retroviral vectors for gene therapy and in vitro models of 2D and 3D tissue constructs, mimicking the natural physiological state for drug discovery purposes.

Typically, the stainless steel bioreactors are cylindrical in shape, the size of bioreactors can vary, ranging from milliliters to several liters, depending on the design and mode of operation across different types of bioprocesses.

Companies Mentioned

  • 2mag
  • 3D Biotek
  • 3Dnamics
  • ABEC
  • Ablaze Export
  • Ablaze Glass Works
  • ABLE & biott
  • Ace Glass
  • Advanced Process Systems (APS)
  • Agilitech
  • Aishengk
  • Aizon
  • AlgaBloom International
  • Alol Instruments
  • Amerging Technologies
  • American Alloy Fabricators
  • Amixon
  • Amstrong Biotech
  • Analytical Technologies
  • Andel Equipment
  • Anton Paar
  • Applikon Biotechnology (Acquired by Getinge)
  • Aroko Bioengineering
  • artelis
  • ARTeSYN BioSolutions
  • AUCTEQ Biosystems
  • Augusta Fiberglass
  • Automated Engineering Services (AES)
  • Avantica Pharmaceuticals
  • B&P Engineering
  • bbi-biotech
  • Beckman Coulter
  • Belach Bioteknik
  • Bellco Glass
  • Berghof Products + Instruments
  • Bevo Tech
  • Bharat Process Equipment
  • Bilfinger Life Science
  • BINDER
  • Bio Techno Vision
  • Bio-Age Equipment & Services
  • BioBridge Healthcare Solutions
  • Biochrome India
  • Bioengineering
  • BioFluid Control Systems
  • Biolinx Labsystems
  • Biomade India
  • Biomatrix Systems & Services
  • BIONET
  • BioPharm Engineered Systems
  • Bioprocess Technology
  • BioReactor Sciences
  • Bioreactors.net
  • Biosan
  • Biostream
  • BIOTECHNO
  • Biotechnologies
  • Biotree
  • BiOZEEN
  • BioZEN Labs
  • BISS TGT
  • BlueSens
  • Borg Scientific
  • Brihat Bio-Engineering
  • Broadley-James
  • Buchiglas
  • Byron Bioreactor Technologies
  • Carelab Technology
  • Cassia Siamia Technologies
  • Celartia
  • Celeritus Engineering
  • Cell Culture Company
  • CELLEC Biotek
  • Cellexus
  • Celltainer Biotech
  • CelVivo
  • Centrion
  • CerCell
  • CESCO Bioengineering
  • Chema Prozeß- und Systemtechnik
  • Chemglass Life Sciences
  • Chemiplant Engineering
  • Chemtrix
  • Cleaver Scientific
  • Codex Research
  • Corning
  • Cultiply
  • Culturing Solutions
  • Cytiva
  • D D Automation & Engineers
  • DCI-Biolafitte
  • De Dietrich Process Systems
  • Designinnova (Subsidiary of Arrow Weighing System)
  • DHRUV FABROTECH
  • Distek
  • Doga
  • Dyna Biotech
  • EASTBIO (Zhenjiang East Biotech Equipment and Technology)
  • Eco Green Technologies
  • edesign Valvtec
  • Electrolab Biotech
  • Endülüs Krom
  • Ensofa Projects
  • Eppendorf
  • Erbi Biosystems (Acquired by Merck)
  • Esco
  • Fabitech
  • Fermentec
  • Fermenter Bioreactor India
  • Fermetec Resources
  • Fermex Solutions
  • FiberCell Systems
  • FIERUS Rohr- & Anlagenbau Druckbehälterbau
  • Flexcell International
  • Flotek
  • Frings
  • Fuzhou FUL Fluid Equipment & Pharmaceutical
  • G&F Manufacturing Company
  • G&G Technologies
  • Gak Equipments and Technologies
  • Galbino Technology
  • GMM Pfaudler
  • GOAVEC Engineering
  • Gongyi Yuhua Instrument
  • GPC Bio
  • H.E.L
  • Hamilton
  • Harvard Apparatus (Subsidiary of Harvard Bioscience)
  • Henan Lanphan Industry
  • Hexamide Agro Tech
  • High Purity New England
  • HiTec Zang
  • idoneus
  • IKA
  • ILS Automation
  • Industrial Plankton
  • INFORS HT
  • Innova Bio-Meditech
  • Inofinity Tech
  • INOXPA
  • International Filter Products
  • ITB Biopharm
  • Jinzong Machinery
  • KARADANI ENGINEERING
  • KERONE Engineering Solutions
  • KNIK Technology
  • Krishna Scientific Suppliers
  • Kuhner shaker
  • KYNOTA (A subsidiary of NECI)
  • Labfirst Scientific Instruments
  • Labmate Scientific
  • Labotronics
  • Labtronixed
  • LAMBDA Laboratory Instruments
  • Lark innovative Fine Teknowledge
  • LEBAS INDUSTRIES
  • Lee Industries
  • Lelesil Innovative Systems
  • LePure Biotech
  • Liaoyang Sinotech Technology Development
  • Liquidyne
  • Made in Brunel
  • Madhav Automation & STP Solutions
  • Magic Technology
  • Major Science
  • Manidharma Biotech
  • Maruti Engineering
  • Materia Nova
  • MDX Biotechnik International
  • Mecgene Instrument Technologies
  • Membio
  • Merck
  • MicroDigital
  • Motors India
  • MSM Process Solutions
  • MURHOPYE SCIENTIFIC COMPANY
  • Nanjing A & M Technology
  • Nanjing Ningbo Instrument
  • Nanjing Ningkai Instrument
  • Nantong Sanjing Chemglass
  • Napro Scientific
  • NeoTech Water Solutions
  • Nes India Engineers
  • New Horizon Biotechnology
  • Nordic Engineering
  • Novaferm
  • Ollital Technology
  • Omni Life Science
  • OmniBRx Biotechnologies
  • Padmatech Industries
  • Pall Corporation
  • Paragon Bio-Engineering
  • Parker Hannifin
  • Parr Instrument Company
  • Patel Agro Biotech
  • Paul Mueller Company
  • Pavika Equipments And Technologies
  • PBS Biotech
  • PendoTECH
  • PerfuseCell
  • Peschl Ultraviolet
  • Pharmabios
  • Pharmacon
  • Phenometrics
  • Pierre Guérin
  • Praj HiPurity Systems
  • Prime Care Technology
  • ProlifeCell
  • PRS Bio & Automation Solutions
  • Q Labtech
  • Qi Yu Industry (Shanghai)
  • Quantek Instruments
  • Quark Glass (Acquired by Andrews Glass)
  • Quinxell Technologies
  • Real Ions Technologies
  • RealBio Technology
  • Refine Technology
  • Regemat 3D
  • Regenere 3D
  • Repligen
  • ReproCell
  • Rigenerand (Acquired by Evotec)
  • Roch Mechatronics
  • Roggetec Mader
  • Rotech Bioengineering
  • Ruland
  • S2 Engineering Industries
  • Sartorius
  • SATAKE MultiMix
  • Scigenics
  • Scinus
  • Sentinel Process Systems
  • Sepragen
  • Shakti Lab Equipment
  • Shanghai Bailun Biological Technology
  • Shanghai Baoxing Bio-Engineering Equipment (BXBIO)
  • Shanghai Iven Pharmatech Engineering
  • Shanghai Ritai Medicine Equipment Project
  • Shanghai Shenheng Biological Technology
  • Shanghai Yuanhuai Industrial
  • Shanghai Yuhua Instrument Equipment
  • Sharad Agencies
  • Shree Bhagwati Machtech
  • Shree Biocare
  • SKE Research Equipment
  • SM Biosystems
  • Solaris Biotech
  • Solida Biotech
  • SpectraA Technology Solutions
  • Spectrochem Instruments
  • SpinChem
  • SS Engineers
  • Steel-Pro
  • StemCell Systems
  • Subitec
  • Sunrise Process Equipments
  • Super Scientific Works
  • Synthecon
  • Syrris
  • SYSBIOTECH
  • System Technik Deutschland (SYSTAG)
  • T&J Bioengineering
  • TA Instruments (Subsidiary of Waters Corporation)
  • Techniserv
  • Techno Service
  • TECNIC
  • Telstar (Subsidiary of Azbil)
  • Thermo Fisher Scientific
  • Trace Bio Tech
  • Trident Labortek
  • TRL Instruments
  • Truking Technology
  • Univercells Technologies
  • V R Process Engineering Consultants
  • VERDOT Ips²
  • Vinay Enterprises
  • Vivek Chem Fabs
  • Vogelbusch Biocommodities
  • VTU Group
  • W. B. Moore
  • Wenzhou Chinz Machinery
  • Wenzhou Daysly Technology
  • Wenzhou Kosun Fluid Equipment
  • Wenzhou Longqiang Machinery Tech
  • Winkels
  • WUHAN CEKG TECH
  • Wuxi Zhanghua Pharmaceutical Equipment
  • XACT Systems
  • Yadavaran Rafea Isfahan Research & Engineering
  • ZAID STEEL
  • Zellwerk
  • ZETA
  • Zhejiang JYSS Bio-Engineering
  • Zhejiang Shuangzi Intelligent Equipment
  • Zhengzhou Keda Machinery and Instrument Equipment
  • Zhengzhou Laboao Instrument Equipment (LABAO)
  • Zhengzhou Mingyi Instrument Equipment

Methodology

 

 

Loading
LOADING...

Table Information